FDA gives emergency approval to COVID-19 antibody serum used to treat Trump
The approval of Regeneron’s treatment is second in a month.
The Food and Drug Administration on Saturday evening gave emergency approval for a COVID-19 antibody treatment used to treat President Trump.
Regeneron’s antibody serum was authorized for treating mild to moderate coronavirus in adults, as well as children 12 years or older who have a high risk of progressing to severe disease.
Regeneron applied for emergency FDA approval in October after Trump praised the treatment in a Twitter video.
The FDA earlier this month also issued an emergency use authorization for another COVID-19 antibody treatment made by Eli Lilly.
News, Not Noise
- Once-secret FBI informant reports reveal wider-ranging operation to spy on Trump campaign
- As Sen. Manchin opposes Tanden nomination, Klain says 'he doesn't answer to us at the White House'
- More than two dozen House Democrats ask Biden to relinquish sole authority to launch nuclear weapons
- GOP Rep: 'Should MSNBC be carried after years of pushing the false Russia collusion narrative?'
- Amazon quietly ends sales of books it labels 'hate speech'